Tenon Medical Inc.

NASDAQ: TNON · Real-Time Price · USD
1.41
0.01 (0.71%)
At close: Aug 15, 2025, 3:59 PM
1.38
-1.78%
After-hours: Aug 15, 2025, 06:54 PM EDT

Tenon Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.95M 3.28M 3.28M 3.31M 3.37M 3.21M 2.93M 2.4M 1.66M 1.05M 691K 466.8K 328.8K 215.8K 159.8K 120.44K 53.64K 45.23K
Cost of Revenue
1.61M 1.72M 1.73M 1.71M 1.65M 1.77M 1.84M 1.92M 1.81M 1.54M 1.33M 864.77K 580.77K 318.77K 54.77K 47.13K 31.41K 25.83K
Gross Profit
1.34M 1.56M 1.55M 1.61M 1.72M 1.45M 1.09M 475K -154K -484K -641K -397.97K -251.97K -102.97K 105.03K 73.31K 22.23K 19.4K
Operating Income
-12.92M -13.94M -13.77M -13.73M -13.9M -14.35M -15.73M -20.51M -20.4M -21.53M -18.73M -13.36M -12.19M -8.35M -6.46M -4.1M -2.11M -610.21K
Interest Income
n/a n/a n/a 7K 7K 44K 44K 117K 117K 80K 80K n/a n/a n/a n/a 106.47K 128.97K 148.41K
Pretax Income
-12.66M -13.71M -13.67M -13.72M -13.87M -14.33M -15.58M -20.35M -20.19M -21.39M -18.92M -13.85M -13.05M -9.23M -7.08M -4.54M -2.31M -771.26K
Net Income
-12.66M -13.71M -13.67M -13.72M -13.87M -14.33M -15.53M -20.27M -20.02M -21.26M -19.11M -14.07M -13.33M -9.48M -7.05M -4.45M -2.23M -673.44K
Selling & General & Admin
11.84M 12.88M 12.87M 12.93M 13.13M 13.11M 13.8M 17.7M 16.9M 17.95M 15.26M 10.15M 9.33M 6.05M 4.85M 3.19M 1.72M 386.99K
Research & Development
2.42M 2.63M 2.6M 2.73M 2.81M 3M 3.16M 3.28M 3.34M 3.1M 2.83M 2.81M 2.61M 2.19M 1.72M 979.69K 414.34K 242.61K
Other Expenses
n/a n/a n/a -151K -151K -151K -151K -57K -38K -17K -18K 38.77K 19.77K -1.23K -1.23K -1K -1K -1K
Operating Expenses
14.26M 15.5M 15.48M 15.5M 15.78M 15.95M 16.82M 20.99M 20.24M 21.05M 18.08M 12.96M 11.94M 8.25M 6.57M 4.17M 2.13M 630.25K
Interest Expense
-68K -68K -34K 34K 38K 38K 4K 4K n/a 88K 362K 642.81K 909.81K 883.81K 620.81K 340K 73K 11K
Selling & Marketing Expenses
5.05M 5.38M 5.11M 5.38M 5.7M 6.13M 6.78M 10.4M 9.52M 9.58M 7.83M 3.53M 3.44M 2.41M 2.14M 1.48M 925.32K 22.81K
Cost & Expenses
15.87M 17.22M 17.04M 17.05M 17.27M 17.56M 18.66M 22.91M 22.06M 22.59M 19.42M 13.83M 12.52M 8.57M 6.62M 4.22M 2.16M 656.08K
Income Tax Expense
n/a n/a n/a n/a n/a -31.09K -87.08K -110.08K -201.09K -138K 192K 215.43K 306.43K 264.43K -9.57K -10K -10K n/a
Shares Outstanding (Basic)
7.59M 3.6M 1.21M 877K 468.63K 356.63K 318.13K 285K 163.13K 140.5K 140.46K 140.5K 105.28K 12.38K 12.6K 11.49K 10.38K 10.38K
Shares Outstanding (Diluted)
7.59M 3.6M 1.21M 877K 468.63K 356.63K 318.13K 285K 163.13K 140.5K 140.46K 140.5K 105.28K 12.38K 12.6K 11.49K 10.38K 10.38K
EPS (Basic)
-7.54 -15.34 -24.36 -31.67 -39.73 -57.84 -82.19 -128.62 -139.5 -165.36 -321.12 -490.36 -671.57 -779.92 -609.06 -406.79 -214.62 -64.91
EPS (Diluted)
-7.54 -15.34 -24.36 -31.67 -39.73 -57.84 -82.19 -128.62 -139.5 -165.36 -321.12 -490.36 -671.57 -779.92 -609.06 -406.79 -214.62 -64.91
EBITDA
-12.46M -13.28M -12.98M -13.04M -13.25M -13.77M -15.13M -19.99M -19.86M -21M -18.27M -12.95M -11.9M -8.17M -6.35M -3.84M -1.79M -186.7K
EBIT
-9.89M -13.71M -13.64M -13.67M -13.81M -14.27M -15.56M -20.36M -20.2M -21.31M -18.56M -13.21M -12.14M -8.35M -6.46M -4.1M -2.11M -611.25K
Depreciation & Amortization
452K 602K 655K 625K 565K 506K 426K 354K 328K 308K 289K 261.8K 233.8K 174.8K 302.8K 449.32K 507.13K 610.21K